Compare TG Therapeutics Inc (TGTX) vs Weibo Corp (WB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
TG Therapeutics Inc vs Weibo Corp — how do they compare? TG Therapeutics Inc trades at $54 (market cap $8.26B), while Weibo Corp trades at $8 (market cap $1.95B). The key difference: TG Therapeutics Inc is far larger — about 4.2× Weibo Corp's market cap, and Weibo Corp pays a 7.63% dividend while TG Therapeutics Inc pays none. Which is the better fit depends on your goals.
| TGTX | WB | |
|---|---|---|
Market Cap | $8.26B | $1.95B |
Sector | Health | Media |
52-Week High | $59.06 | $12.83 |
52-Week Low | $26.39 | $7.20 |
Enterprise Value | $8.50B | $1.22B |
Dividend Yield | — | 7.63% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About TG Therapeutics Inc
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →About Weibo Corp
Weibo is the largest social media platform in China. As of 2020, Weibo had 521 million monthly active users and 225 million daily active users, many of whom are drawn there by the millions of key opinion leaders in entertainment, sports, and business circles. Sina is the major shareholder, holding 44.7% of shares and with 70.8% voting power.
Read more on WB →
